Zhongheng Group: The company's pharmaceutical research and development direction is mainly concentrated in the field of traditional Chinese medicine research and development, mainly in the fields of cardiovascular and cerebrovascular, classic traditional Chinese medicine and other fields Post date May 17, 2022 — 09:30 Post Lock Read More Zhongheng Group: The company has formed an industrial layout of Chinese patent medicines, APIs, chemical medicines, generic medicines, biological medicines, pharmaceutical distribution, and daily chemical supplies Post date May 17, 2022 — 09:25 Post Lock Read More Zhongheng Group: Corporate Governance Standardizes, Production and Operation are All Normal_Oriental Fortune Net Post date May 17, 2022 — 09:24 Post Lock Read More Zhongheng Group: At present, the company's masks and other protective products account for a small proportion of the company's consolidated revenue and profits Post date May 17, 2022 — 09:21 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Lai Mei Pharmaceutical's latest announcement: "Nano-carbon iron suspension injection" approved for clinical trials_Stock News_Market_Zhongjin Online Post date May 16, 2022 — 23:14 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 4.92% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 12, 2022 — 07:55 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group: The company has formed an industrial layout of Chinese patent medicines, APIs, chemical medicines, generic medicines, biological medicines, pharmaceutical distribution, and daily chemical supplies Post date May 17, 2022 — 09:25 Post Lock Read More Zhongheng Group: Corporate Governance Standardizes, Production and Operation are All Normal_Oriental Fortune Net Post date May 17, 2022 — 09:24 Post Lock Read More Zhongheng Group: At present, the company's masks and other protective products account for a small proportion of the company's consolidated revenue and profits Post date May 17, 2022 — 09:21 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Lai Mei Pharmaceutical's latest announcement: "Nano-carbon iron suspension injection" approved for clinical trials_Stock News_Market_Zhongjin Online Post date May 16, 2022 — 23:14 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 4.92% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 12, 2022 — 07:55 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group: Corporate Governance Standardizes, Production and Operation are All Normal_Oriental Fortune Net Post date May 17, 2022 — 09:24 Post Lock Read More Zhongheng Group: At present, the company's masks and other protective products account for a small proportion of the company's consolidated revenue and profits Post date May 17, 2022 — 09:21 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Lai Mei Pharmaceutical's latest announcement: "Nano-carbon iron suspension injection" approved for clinical trials_Stock News_Market_Zhongjin Online Post date May 16, 2022 — 23:14 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 4.92% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 12, 2022 — 07:55 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group: At present, the company's masks and other protective products account for a small proportion of the company's consolidated revenue and profits Post date May 17, 2022 — 09:21 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Lai Mei Pharmaceutical's latest announcement: "Nano-carbon iron suspension injection" approved for clinical trials_Stock News_Market_Zhongjin Online Post date May 16, 2022 — 23:14 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 4.92% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 12, 2022 — 07:55 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Lai Mei Pharmaceutical's latest announcement: "Nano-carbon iron suspension injection" approved for clinical trials_Stock News_Market_Zhongjin Online Post date May 16, 2022 — 23:14 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 4.92% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 12, 2022 — 07:55 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Lai Mei Pharmaceutical's latest announcement: "Nano-carbon iron suspension injection" approved for clinical trials_Stock News_Market_Zhongjin Online Post date May 16, 2022 — 23:14 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 4.92% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 12, 2022 — 07:55 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Shanghai Investment Morgan Power Select Hybrid C Net Value Up 4.92% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 12, 2022 — 07:55 Post Lock Read More Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Shanghai Investment Morgan Power Select Hybrid C Net Value Up 3.66% Shanghai Investment Morgan_Sina Finance_Sina.com Post date May 11, 2022 — 08:06 Post Lock Read More Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group's pharmaceutical R&D energy storage food performance has soared, and diversified operations are now effective Post date May 7, 2022 — 14:03 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
"Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 03:39 Post Lock Read More "Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
"Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network Post date May 2, 2022 — 01:59 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pharmaceutical research and development has accumulated energy, food performance has soared, and the diversification of Zhongheng Group is now effective_Individual Stock Information_Market_Zhongjin Online Post date April 25, 2022 — 00:07 Post Lock Read More Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yulong Shares (601028): 2021 Independent Director Debriefing Report CFi.CN Zhongcai Network Post date April 20, 2022 — 04:27 Post Lock Read More The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The net profit is almost halved, and Zhongheng Group has come to the crossroads of transformation Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group (600252): Guangxi Wuzhou Zhongheng Group Co., Ltd. on the provision for asset impairment in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group (600252): 2021 Performance Report of the Audit Committee of the Board of Directors of Guangxi Wuzhou Zhongheng Group Co., Ltd. CFi.CN Post date April 17, 2022 — 21:40 Post Lock Read More Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhongheng Group (600252): Special Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Deposit and Actual Use of Raised Funds in 2021- CFi.CN Zhongcai Network Post date April 17, 2022 — 21:40 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times Post date April 7, 2022 — 09:25 Post Lock Read More Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm Post date April 7, 2022 — 09:20 Post Lock Read More
Caishen.CoCaishen.Co